With the tax credits secured, EpiBone committed to moving its headquarters to 95 Greene St. in Jersey City. The base will include research and development facilities and clean room space.

is pleased to announce a long-term lease with EpiBone, for 28,000 square feet at 95 Greene Street in Jersey City, the first lab-ready life sciences property in Jersey City, NJ. A revolutionary ...

JERSEY CITY, N.J., July 24, 2023 /PRNewswire/ -- EpiBone has received Investigational New Drug (IND) clearance from the FDA to begin testing its lab-grown knee cartilage in humans. The treatment ...

JERSEY CITY, N.J., Nov. 15, 2023 /PRNewswire/ -- Nina Tandon, PhD, MBA, co-founder and CEO of EpiBone, has been appointed to Columbia Engineering's Board of Visitors (BOV) for a three-year term.

Hackensack Meridian Health invested in regenerative medicine company EpiBone Inc. Brooklyn-based EpiBone focuses on the growth of personalized bone and cartilage grafts using stem cell ...